Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Infection01:20

Infection

8.7K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.7K
Stages of Infection01:26

Stages of Infection

58.9K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
58.9K
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

43
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
43
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

26
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
26
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

410
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
410
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.4K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.4K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Nature communications·2026
Same author

Responding Appropriately to Safety Signals in Infants Exposed to the 6-month BDLLfx/BDLCfz Regimen In Utero.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

The looming crisis of bedaquiline-resistant tuberculosis and a promising way forward.

The Lancet. Infectious diseases·2026
Same author

Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

"Six months is a lot of time to lie": Anticipated stigma, disclosure and treatment preferences among participants in a tuberculosis therapeutic trial.

Research square·2026
Same author

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.

The Lancet. Infectious diseases·2025

Video Experimental Relacionado

Updated: Sep 8, 2025

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.4K

Una "infección terminal"

Jennifer Furin1

  • 1Division of Infectious Diseases, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
|August 20, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La resistencia a los antimicrobianos (AMR) tiene un impacto significativo en la atención del paciente, especialmente en las infecciones complejas. Esta reflexión explora estrategias de colaboración para los proveedores de enfermedades infecciosas (ID) para manejar eficazmente los casos de AMR desafiantes.

Palabras clave:
Los antibióticosResistencia a los antimicrobianoscolaboracionespacientes internadosCuidados paliativos

Más Videos Relacionados

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

528
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

10.6K

Videos de Experimentos Relacionados

Last Updated: Sep 8, 2025

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

2.4K
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

528
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

10.6K

Área de la Ciencia:

  • Medicina Clínica
  • Enfermedades infecciosas
  • Microbiología

Sus antecedentes:

  • La resistencia a los antimicrobianos (AMR) representa una amenaza significativa para la salud mundial y los resultados para los pacientes.
  • La gestión de infecciones complejas en pacientes con AMR presenta desafíos sustanciales para los proveedores de atención médica.
  • Las prácticas clínicas actuales requieren estrategias mejoradas para combatir el aumento de la resistencia antimicrobiana.

Objetivo del estudio:

  • Reflexionar sobre los encuentros clínicos relacionados con la resistencia a los antimicrobianos (AMR).
  • Identificar y proponer posibles enfoques de colaboración para el manejo de infecciones complejas.
  • Mejorar el tratamiento clínico de los pacientes afectados por AMR.

Principales métodos:

  • Análisis retrospectivo de encuentros clínicos con AMR.
  • Reflexión cualitativa sobre los desafíos a los que se enfrentan los proveedores de servicios de enfermedades infecciosas.
  • Exploración de modelos de colaboración interdisciplinaria.

Principales resultados:

  • Las infecciones complejas debidas a la resistencia antimicrobiana requieren estrategias de manejo multifacéticas.
  • La colaboración entre los profesionales de la salud puede mejorar los resultados de los pacientes.
  • La identificación de enfoques de colaboración específicos es crucial para una gestión eficaz de la RAM.

Conclusiones:

  • La gestión eficaz de la AMR requiere un enfoque de colaboración entre los proveedores de ID y otros especialistas.
  • Para combatir la resistencia a los antimicrobianos es esencial seguir investigando y aplicando modelos de colaboración.
  • Abordar la resistencia a los antimicrobianos requiere un esfuerzo unificado y estratégico en el ámbito clínico.